Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics of cardiovascular disease: genes and polymorphisms in pathways underlying atherosclerosis and clinical events.

Journal of advanced research·2026
Same author

High postprandial endotoxemia is associated with recurrence of cardiovascular events in patients with coronary heart disease: from the CORDIOPREV randomized clinical trial.

The American journal of clinical nutrition·2026
Same author

Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study.

European heart journal·2026
Same author

Atmospheric Dispersal and Local Drivers Shape Snow and Air Microbial Communities in the Western Antarctic Peninsula.

Environmental microbiology·2026
Same author

Influence of age and diet on the expression of microRNAs in coronary heart disease: Findings from the CORDIOPREV study.

Maturitas·2026
Same author

Consensus of the Spanish Society of Arteriosclerosis and the Spanish Society of Internal Medicine on the Mediterranean Diet and Health: A comprehensive approach beyond nutrients.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026

Related Experiment Video

Updated: Jul 11, 2026

Simple and Effective Procedure for Hemostasis in Mouse Arteries
05:34

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

Olive oil and the haemostatic system.

Jose Lopez-Miranda1, Javier Delgado-Lista, Pablo Perez-Martinez

  • 1Lipid and Arteriosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain. jlopezmir@uco.es

Molecular Nutrition & Food Research
|September 21, 2007
PubMed
Summary

The Mediterranean diet, rich in virgin olive oil, offers significant health benefits beyond heart health. It positively impacts blood clotting factors, promoting longevity and reducing disease risk.

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Related Experiment Videos

Last Updated: Jul 11, 2026

Simple and Effective Procedure for Hemostasis in Mouse Arteries
05:34

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Area of Science:

  • Nutrition Science
  • Cardiovascular Health
  • Dietary Interventions

Background:

  • The Mediterranean diet (MD) is associated with increased longevity and reduced rates of cardiovascular disease, cancer, and age-related cognitive decline.
  • Olive oil is a principal component of the MD, providing substantial energy and bioactive compounds.
  • Traditional understanding of MD benefits focused on lipoprotein metabolism, but emerging evidence highlights effects on hemostasis.

Purpose of the Study:

  • To review the health benefits of diets enriched in virgin olive oil.
  • To explore the impact of virgin olive oil on various components of hemostasis.
  • To discuss the mechanisms behind these observed health benefits.

Main Methods:

  • Literature review of studies investigating virgin olive oil consumption and its effects on health markers.
  • Analysis of research focusing on hemostatic factors, including platelet function, thrombogenesis, and fibrinolysis.
  • Examination of biochemical markers related to blood coagulation and clot formation.

Main Results:

  • Diets enriched with virgin olive oil can decrease platelet sensitivity to aggregation and lower plasma levels of von Willebrand factor and thromboxane B2.
  • Virgin olive oil intake may reduce fasting Factor VII plasma levels and modulate its postprandial activation.
  • Chronic consumption of virgin olive oil can decrease Tissue Factor expression in mononuclear cells and enhance fibrinolytic activity, reducing Plasma Activator Inhibitor type-1 levels.

Conclusions:

  • Virgin olive oil possesses multifaceted health benefits extending to hemostasis, contributing to the overall advantages of the Mediterranean diet.
  • The bioactive components in virgin olive oil play a crucial role in modulating blood coagulation and fibrinolysis.
  • Further research into virgin olive oil's impact on cardiovascular health and longevity is warranted.